Search

You searched for "consent"

888 results found

Cutting-edge or over-hyped? Evaluating the role of robotic surgery in the management of renal cell carcinoma

3 May 2024 | | URO - Urologic Oncology
The quest for a minimally-invasive approach to major abdominal surgery finds its roots at the start of the previous century, when Georg Kelling first described the technique of ‘ceolioscopy’ to inspect intraabdominal organs in 1901 [1]. Since those early days,...

Lasers in urology

3 July 2026 | | URO - Technology
1. What does LASER stand for? 2. What elements are involved and how is a LASER created? 3. The following cases involve laser surgery. Can you diagnose the pathology, identify which type of lasers can be used, and their wavelengths?...

Comparing NSAIDs with antibiotics in the treatment of uncomplicated UTIs in women

1 March 2016 | | URO - Functional / Reconstructive Urology
Uncomplicated urinary tract infections (UTIs) are a common presentation in primary care, however there is increasing concern regarding antibiotic use and resistant organisms. In this double-blind randomised German study, the authors seek to establish if ibuprofen 400mg three times a...
European Urology journal cover image.

Solifenacin and mirabegron are safe and effective in combination

1 September 2015 | | URO - Functional / Reconstructive Urology
Antimuscarinic agents remain the mainstay of medical management of bladder overactivity. Limited somewhat by their tolerability, the new agent mirabegron, a β3-adrenoreceptor agonist, has been approved as an alternative. There is little known however about the possible synergistic effects of...
BJUI International journal cover image.

Percutaneous nephrolithotomy: wisdom, dogma, paradigm and myths

4 November 2025 | | URO - Urologic Oncology
A non-transpapillary technique appears to ease access to the kidney – the most critical step in percutaneous nephrolithotomy (PNL) – when compared to the classic transpapillary approach. Remarkably, the earliest descriptions of percutaneous access by Goodwin et al. in 1955...

In conversation with Tim O’Brien

1 December 2020 | URO - Core Urology
We were delighted to catch up with Tim O’Brien, President of BAUS, about his career highlights and plans for the association. Can you tell us a little bit about what led you into the field of urology and the highlights...

Andrology (2020)

4 May 2020 | | URO - Andrology
Case 1 What is the diagnosis based on the blood test, and how is the diagnosis made? What additional blood tests are required? What are the clinical manifestations of this? What are the options / modes of delivery for treatment?...

A laboratory in your pocket

7 January 2026 | | URO - Technology
In this series of articles, I show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk) and in this one I am joined by Mary Garthwaite, retired urologist and Chair of The...

The assessment and medical treatment of LUTS secondary to BPH

1 November 2016 | URO - Functional / Reconstructive Urology
The term benign prostatic hyperplasia (BPH) describes prostate enlargement due to non-cancerous processes. Several aetiological mechanisms are involved, including hormonal and vascular alterations; abnormal regulation of apoptosis; and prostatic inflammation, which may stimulate cellular proliferation. With ageing, prostate enlargement can...

In conversation with Neil Harvey

21 December 2021 | URO - Core Urology
We were delighted to catch up with Neil Harvey, Chair of the BAUS Section of Trainees (BSoT) about his life as a trainee urologist and his plans for the association. Can you tell us a little bit about what led...

In conversation with Nadine Coull

5 October 2022 | URO - Core Urology
We were delighted to chat to Nadine Coull, the new President of the Royal Society of Medicine Section of Urology about her career so far and aims for the year ahead. Can you tell us a little bit about what...

Digital Twins: From NASA to the clinic

7 May 2026 | | URO - Technology
Clinical practice generates an enormous amount of patient data – histories, observations, blood results, imaging and molecular biomarkers. The problem is that these data streams rarely talk to each other. Instead, we use them in isolation, when what we actually...